GLP1R and type 2 diabetes mellitus: Currently, three drug classes approved for T2D treatment exhibit high antihyperglycemic efficacy and promote weight and visceral fat loss: SGLT-2is, GLP-1RAs, and the dual GLP-1/GIP agonist tirzepatide [70,71,72,73,74,75].